lucanthone has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhary, P; Chowdhury, SM; Lee, S; Naidu, M; Peña, LA; Sanchez, Z; Sitharaman, B; Suresh Kumar, MA; Surhland, C; Waring, M | 1 |
| Agarwal, R; Chaudhary, P; Cunha, L; Liu, Y; Mezei, M; Naidu, MD; Pena, LA; Sanchez, Z; Shen, M; Waring, MJ; Wilson, DM; Wilson, SH | 1 |
2 other study(ies) available for lucanthone and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Graphene nanoribbons as a drug delivery agent for lucanthone mediated therapy of glioblastoma multiforme.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Coculture Techniques; DNA-(Apurinic or Apyrimidinic Site) Lyase; Drug Delivery Systems; Flow Cytometry; Glioblastoma; Graphite; Humans; Hydrogen-Ion Concentration; Lucanthone; Mice; Microscopy, Electron, Transmission; Nanotubes, Carbon; Neoplasm Transplantation; Neuroglia; Oxygen; Rats; Stem Cells | 2015 |
Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.
Topics: Cell Line, Tumor; Circular Dichroism; DNA; DNA-(Apurinic or Apyrimidinic Site) Lyase; Glioblastoma; Humans; Hycanthone; Hydrogen Bonding; Indoles; Inhibitory Concentration 50; Lucanthone; Mutation; Oxidation-Reduction; Plasmids; Protein Binding; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2011 |